Skip to main content

US Wrap: Industrial-based reverse convertibles dominate issuance

Reverse convertibles dominated yesterday's US public offerings, with Royal Bank of Canada (RBC) issuing most of the notes, and industrials providing the underlying on all but one of the notes, which is based on the Las Vegas Sands resort.

RBC's three-month reverse convertible notes linked to Las Vegas Sands pay a monthly income equivalent to a 13.6% annual rate. There is a 65% protection barrier, after which investors' capital will be lost at a rate of 1:1. The resort also provides the underlying for Royal Bank of Scotland's three-month notes, which offer a 10.5% annual rate.

The S&P index is again a popular underlying. Bank of America's review product is a two-year investment based on the index. There are three review dates during the life of the investment; if the index is at or above its initial level on any of these dates, the product will kick out and investors will receive a fixed payout. If the index finishes below 90% of its strike level, capital will be lost on a 1:1 basis.

Eksportfinans is the only non-bank issuer to join the offerings. The Norwegian institution for export and financing has issued an accelerated growth product with no principal protection but with a 300% participation rate and a cap of 13–17%. The accelerated return notes are linked to the MSCI EAFE index of European, Australasian and Asian equities and are investments of one year and two months.

spmnew20100226

 

 

 

 

 

 

 

 

 

 

Source: FVC and SEC filings

For access to analysis of the US structured products market: www.structurededge.com

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here